Please complete the CAPTCHA to continue
@disruptivepharma.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Peter Åsberg is listed as CEO at Disruptive Pharma AB at Disruptive Pharma AB, based in Greater Stockholm Metropolitan Area, Sweden, Sweden. AeroLeads shows a work email signal at disruptivepharma.com and a matched LinkedIn profile for Peter Åsberg.
Peter Åsberg previously worked as CEO at Disruptive Pharma Ab and Sr Vice President - Pharma at Disruptive Materials Ab. Peter Åsberg holds Phd, Biomolecular And Organic Electronics from Linköping University.
This section adds company-level context without repeating Peter Åsberg's masked contact details.
AeroLeads found 1 current-domain work email signal for Peter Åsberg. Compare company email patterns before reaching out.
Life science and business professional with extensive experience within the pharma/biotech industry. An executive impacting corporate performance and leadership of companies within the life science sector. Role responsibilities includes executive management, business strategy, commercialization, business development, intellectual property strategy, pharmaceutical development, and project management. Enjoying strategic work towards realization of company goals, reaching licensing agreements and development agreements that enhance business growth. Experienced business development and project manager that leads development in the cross-section between life science and technology. Management skills: Executive and strategic leadership within biotech and pharma industry.Strategic experience: Member of the Board of directors; Evaluation of business opportunities, Establishment of successful Business Models.
Listed skills include Biotechnology, Lifesciences, Commercialization, Life Sciences, and 24 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Disruptive Pharma AB is engaged in the development and commercialization of Improved and Safe drug products based on Pharma-MMC, our patented drug delivery technology. Pharma-MMC enables amorphous API stabilization, solubility enhancement and for unique drug formulations. As CEO, my focus will be on leadership, business development and identifying.
Uppsala, SE
Disruptive Materials - Pharma - develops drug products based on Pharma-MMC, a pharmaceutical grade mesoporous magnesium carbonate material. Pharma-MMC is a proprietary drug delivery technology for amorphous stabilization and solubility enhancement of drug substances and for unique drug formulations - addressing unmet industry need. My focus is strategic.
Uppsala, SE
Disruptive Materials Pharma unit develops pharmaceutical grade mesoporous magnesium carbonate material (Pharma-MMC) within drug delivery applications. The properties of Pharma-MMC allow drugs to be loaded to achieve a controlled release or solubility improvement. My focus is mainly on commercialization of the world-record breaking Pharma-MMC drug delivery.
Olink Bioscience is focused on developing and commercializing enabling molecular tools for life science research and molecular diagnostics. Our primary goal is to develop high-end products and/or tools meeting unmet clinical and research needs with a significant market potential.Our pipeline contains exciting projects targeting unmet industry needs. We are.
Ahmedabad, Gujarat, IN
Cadila Pharmaceuticals is one of the largest pharmaceutical companies in India with an impressive track record within clinical development and bringing innovative products to the market. Our product basket includes branded and generic formulations covering more than 45 therapeutic segments, active pharmaceutical ingredient (API) and intermediates. I am.
Melbourn, Herts, GB
Aegate’s core principle is Patient Safety: To protect patients from falsified, recalled or expired medicines. We operate a highly secure real-time system that verifies the authenticity of medicines instantly. This operates seamlessly from manufacturer to pharmacy, and fully meets the requirements of European legislation and fully complies with the.
Our goal is to develop novel treatments for neurodegenerative disorders based on the Company's proprietary technology. I am responsible for all commercial aspects, pharmaceutical development, intellectual property rights and business development. I was one of those who took the initiative to found BioChromix Pharma AB in 2009. It was purely a strategic.
Novel treatments for neurodegenerative disorders based on the Company's proprietary technology.
Stockholm, SE
BioChromix is an exciting company developing breakthrough Imaging, Diagnostics and R&D tools for Alzheimer’s disease (AD). Our products will help scientist to better understand the disease and aid pharmaceutical companies to validate/test new treatments. My main responsibilities as the chief executive officer are to lead and facilitate the development and.
Linköping, Östergötland, SE
Research, instrument development and supervising PhD-students.
Linköping, Östergötland, SE
Applied Biochemistry @ Biomolecular and Organic Electronics
Stockholm, SE
Co-founder and the first chairman of the board. Additional responsibilities included business development, head of R&D and intellectual property rights.
Quick answers generated from the profile data available on this page.
Peter Åsberg works for Disruptive Pharma AB.
Peter Åsberg is listed as CEO at Disruptive Pharma AB at Disruptive Pharma AB.
AeroLeads has found 1 work email signal at @disruptivepharma.com for Peter Åsberg at Disruptive Pharma AB.
Peter Åsberg is based in Greater Stockholm Metropolitan Area, Sweden, Sweden while working with Disruptive Pharma AB.
Peter Åsberg has worked for Disruptive Pharma Ab, Disruptive Materials Ab, Olink Bioscience, Cadila Pharmaceuticals Sweden Ab, and Aegate.
You can use AeroLeads to view verified contact signals for Peter Åsberg at Disruptive Pharma AB, including work email, phone, and LinkedIn data when available.
Peter Åsberg holds Phd, Biomolecular And Organic Electronics from Linköping University.
Peter Åsberg is listed with skills including Biotechnology, Lifesciences, Commercialization, Life Sciences, Drug Discovery, Start Ups, Protein Chemistry, and Patents.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts